Drug Approval | June 14, 2026
Alembic secures USFDA nod for Tretinoin Cream strengthening generics portfolio
The approval clears the company to market a generic version that is therapeutically equivalent to Retin-A Cream
The approval clears the company to market a generic version that is therapeutically equivalent to Retin-A Cream
The fast growing pharma industry in India offers us a wide range of opportunities and we represent the world's leading technology providers in india
Collaboration brings Staart Prime, ChilRun and NikoMom products to Yoginii’s platform, strengthening its family-focused wellness ecosystem and supporting women through motherhood and family care
The move marks one of the most significant coverage expansions yet in obesity care, bringing FDA-approved treatment options further into mainstream insurance plans rather than out-of-pocket reach
We are contributing to the Indian pharmaceutical and laboratory sectors through advanced analytical instrumentation, automated liquid handling, and molecular biology solutions. Our technologies empower research and Quality Control (QC) by ensuring regulatory compliance and streamlined workflows…
Revenue from operations climbed 13% to Rs. 886.87 crore
Company enters women’s personal grooming segment while strengthening pain management portfolio with herbal Ortho Oil
The acquisition complements Gilead’s existing oncology expertise and development infrastructure
ANDA approval for 100 mg and 150 mg capsules targeting idiopathic pulmonary fibrosis opens access to a $3.76 billion market in USA
Developed for today’s fast-paced, visually demanding lifestyles, the lenses are built on ZEISS NeurOptix technology
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
